Literature DB >> 20175202

Frontotemporal dementia: pathology of gait?

Gilles Allali1, Bruno Dubois, Frederic Assal, Elise Lallart, Leonardo C de Souza, Maxime Bertoux, Cédric Annweiler, Francois R Herrmann, Richard Levy, Olivier Beauchet.   

Abstract

The main diagnostic criteria of the behavioural variant of frontotemporal degeneration (bvFTD) include neurobehavioral and dysexecutive syndromes, but not specific gait characteristics although strong relationship between gait and prefrontal functions are increasingly recognized. Accordingly, we tested the hypothesis that patients with bvFTD would have more gait changes than older healthy controls and demented patients with Alzheimer's disease (AD). Sixty subjects were included in the study: 19 with bvFTD, 19 with AD and 22 healthy controls. Mean values and coefficients of variation (CV) of stride time while just walking (i.e., single tasking) and while walking with backward counting (i.e., dual tasking) were measured using the SMTEC-footswitch system. Stride time, mean value, and CV were significantly increased in both patient groups compared with healthy controls during single task or walking alone (P < 0.001) and during dual tasking (P < 0.001). After adjusting for age, Mini-mental examination, psychoactive drugs, gender, and history of previous fall, only the patients with bvFTD group was associated with an increase of CV of stride time during single walking (P < 0.001) and dual tasking (P < 0.001). These data suggest that gait instability during single and dual tasking could represent a supportive argument for bvFTD. In clinical practice, such a diagnosis should be at least considered in any demented patient with gait instability. 2010 Movement Disorder Society

Entities:  

Mesh:

Year:  2010        PMID: 20175202     DOI: 10.1002/mds.22927

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  24 in total

1.  [Gait changes as an early indicator of dementia].

Authors:  M Jamour; C Becker; M Synofzik; W Maetzler
Journal:  Z Gerontol Geriatr       Date:  2012-01       Impact factor: 1.281

2.  Gait control and executive dysfunction in early schizophrenia.

Authors:  Elise Lallart; Roland Jouvent; François R Herrmann; Fernando Perez-Diaz; Xavier Lallart; Olivier Beauchet; Gilles Allali
Journal:  J Neural Transm (Vienna)       Date:  2013-11-08       Impact factor: 3.575

Review 3.  Management of Gait Changes and Fall Risk in MCI and Dementia.

Authors:  Gilles Allali; Joe Verghese
Journal:  Curr Treat Options Neurol       Date:  2017-09       Impact factor: 3.598

4.  The effect of transcranial direct current stimulation on task processing and prioritisation during dual-task gait.

Authors:  James G Wrightson; Rosie Twomey; Emma Z Ross; Nicholas J Smeeton
Journal:  Exp Brain Res       Date:  2015-02-28       Impact factor: 1.972

5.  Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease.

Authors:  Olivier Beauchet; Cyrille P Launay; Gilles Allali; François R Herrmann; Cedric Annweiler
Journal:  Drugs Aging       Date:  2014-05       Impact factor: 3.923

6.  Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases.

Authors:  Patrizia LoPresti
Journal:  Neurochem Res       Date:  2015-09-22       Impact factor: 3.996

7.  Motor imagery of gait in non-demented older community-dwellers: performance depends on serum 25-hydroxyvitamin D concentrations.

Authors:  Olivier Beauchet; Cyrille P Launay; Bruno Fantino; Cédric Annweiler; Gilles Allali
Journal:  Age (Dordr)       Date:  2015-02-21

8.  Episodic memory and executive function impairments in non-demented older adults: which are the respective and combined effects on gait performances?

Authors:  Olivier Beauchet; Cyrille P Launay; Bruno Fantino; Cédric Annweiler; Gilles Allali
Journal:  Age (Dordr)       Date:  2015-07-10

9.  Anti-Dementia Drugs, Gait Performance and Mental Imagery of Gait: A Non-Randomized Open-Label Trial.

Authors:  Olivier Beauchet; John Barden; Teresa Liu-Ambrose; Victoria L Chester; Cedric Annweiler; Tony Szturm; Sébastien Grenier; Guillaume Léonard; Louis Bherer; Gilles Allali
Journal:  Drugs Aging       Date:  2016-09       Impact factor: 3.923

10.  Gait phenotype from mild cognitive impairment to moderate dementia: results from the GOOD initiative.

Authors:  G Allali; C Annweiler; H M Blumen; M L Callisaya; A-M De Cock; R W Kressig; V Srikanth; J-P Steinmetz; J Verghese; O Beauchet
Journal:  Eur J Neurol       Date:  2015-12-14       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.